D.A. Davidson & Co. Thermo Fisher Scientific Inc. Transaction History

D.A. Davidson & Co.

$12.1 Billion
Q4 2024

A detailed history of D.A. Davidson & Co. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 8,740 shares of TMO stock, worth $4.62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,740

Previous 10,158 13.96%

Holding current value

$4.62 Million

Previous $6.28 Million 27.65%

% of portfolio

0.04%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$501.29 - $612.85 $710,829 - $869,021	-1,418 Reduced 13.96%	8,740 $4.55 Million
Q3 2024 Nov 13, 2024	BUY	$531.86 - $624.21 $106,903 - $125,466	201 Added 2.02%	10,158 $6.28 Million
Q2 2024 Jul 31, 2024	BUY	$541.52 - $599.02 $213,900 - $236,612	395 Added 4.13%	9,957 $5.51 Million
Q1 2024 May 13, 2024	BUY	$528.82 - $599.43 $126,387 - $143,263	239 Added 2.56%	9,562 $5.56 Million
Q4 2023 Feb 09, 2024	SELL	$431.41 - $532.94 $246,766 - $304,841	-572 Reduced 5.78%	9,323 $4.95 Million
Q3 2023 Nov 08, 2023	SELL	$498.29 - $574.41 $314,919 - $363,027	-632 Reduced 6.0%	9,895 $5.01 Million
Q2 2023 Aug 10, 2023	SELL	$508.46 - $591.13 $3,559 - $4,137	-7 Reduced 0.07%	10,527 $5.49 Million
Q1 2023 Apr 25, 2023	SELL	$535.0 - $604.82 $1,070 - $1,209	-2 Reduced 0.02%	10,534 $6.07 Million
Q4 2022 Feb 03, 2023	SELL	$484.71 - $571.37 $14,541 - $17,141	-30 Reduced 0.28%	10,536 $5.8 Million
Q3 2022 Nov 07, 2022	SELL	$507.19 - $604.49 $50,719 - $60,449	-100 Reduced 0.94%	10,566 $5.39 Million
Q2 2022 Jul 28, 2022	SELL	$500.9 - $612.21 $88,659 - $108,361	-177 Reduced 1.63%	10,666 $5.8 Million
Q1 2022 May 12, 2022	BUY	$524.0 - $644.92 $7,336 - $9,028	14 Added 0.13%	10,843 $6.41 Million
Q4 2021 Jan 31, 2022	BUY	$569.0 - $667.24 $1,138 - $1,334	2 Added 0.02%	10,829 $7.22 Million
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $83,562 - $100,003	-164 Reduced 1.49%	10,827 $6.19 Million
Q2 2021 Aug 10, 2021	SELL	$441.0 - $508.24 $148,176 - $170,768	-336 Reduced 2.97%	10,991 $5.55 Million
Q1 2021 May 07, 2021	SELL	$439.85 - $518.83 $568,286 - $670,328	-1,292 Reduced 10.24%	11,327 $5.17 Million
Q4 2020 Feb 10, 2021	SELL	$435.06 - $527.66 $29,584 - $35,880	-68 Reduced 0.54%	12,619 $5.86 Million
Q3 2020 Nov 02, 2020	SELL	$359.77 - $441.52 $58,642 - $71,967	-163 Reduced 1.27%	12,687 $5.6 Million
Q2 2020 Aug 10, 2020	SELL	$275.2 - $362.34 $929,350 - $1.22 Million	-3,377 Reduced 20.81%	12,850 $4.66 Million
Q1 2020 May 05, 2020	SELL	$255.3 - $340.05 $63,569 - $84,672	-249 Reduced 1.51%	16,227 $4.61 Million
Q4 2019 Feb 14, 2020	BUY	$271.93 - $328.04 $442,158 - $533,393	1,626 Added 10.95%	16,476 $5.35 Million
Q3 2019 Nov 05, 2019	SELL	$268.46 - $305.43 $380,944 - $433,405	-1,419 Reduced 8.72%	14,850 $4.33 Million
Q2 2019 Aug 13, 2019	SELL	$257.51 - $295.55 $3.57 Million - $4.1 Million	-13,860 Reduced 46.0%	16,269 $4.78 Million
Q1 2019 May 13, 2019	SELL	$212.17 - $273.72 $231,265 - $298,354	-1,090 Reduced 3.49%	30,129 $7.54 Million
Q4 2018 Jan 29, 2019	SELL	$208.47 - $251.98 $101,733 - $122,966	-488 Reduced 1.54%	31,219 $6.99 Million
Q3 2018 Nov 13, 2018	SELL	$205.57 - $244.32 $937,399 - $1.11 Million	-4,560 Reduced 12.57%	31,707 $7.74 Million
Q2 2018 Aug 02, 2018	BUY	$203.14 - $219.53 $196,842 - $212,724	969 Added 2.75%	36,267 $7.51 Million
Q1 2018 May 04, 2018	BUY	$192.98 - $224.11 $60,788 - $70,594	315 Added 0.9%	35,298 $7.29 Million
Q4 2017 Feb 08, 2018	BUY	$182.03 - $200.37 $32,401 - $35,665	178 Added 0.51%	34,983 $6.64 Million
Q3 2017 Nov 08, 2017	SELL	$171.74 - $194.04 $26,619 - $30,076	-155 Reduced 0.44%	34,805 $6.59 Million
Q2 2017 Aug 11, 2017	BUY	N/A	34,960	34,960 $0

Others Institutions Holding TMO

# of Institutions

2,901

Shares Held

343M

Call Options Held

2.09M

Put Options Held

2.73M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $207B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account